FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140450303> ?p ?o ?g. }

• W2140450303 endingPage "102" @default.
• W2140450303 startingPage "91" @default.
• W2140450303 abstract "DNA repair–deficient (xeroderma pigmentosum group A (XPA)) and DNA repair-proficient (normal) human skin fibroblasts were genetically engineered by transformation with a controllable human cytochrome P450 (CYP)1A1 expression vector. Induction of CYP1A1 enabled these cells to metabolize (±)-benzo[a]pyrene-trans-7,8-dihydrodiol (BPD) into a potent cytotoxicant and mutagen. The XPA cells were more susceptible than the normal cells to the cytotoxic effects of both CYP1A1-metabolized BPD and exogenously supplied (±)-antibenzo[a]pyrene-trans-7,8-dihydrodiol-9, 10-epoxide (BPDE). Furthermore, the differential cytotoxicity between XPA and normal cells induced by CYP1A1-metabolized BPD was 8.4-fold greater than that induced by exogenously supplied BPDE. The two cell lines had similar CYP1A1 activities, suggesting that a difference in metabolic potential was not the cause of the differential response to BPD. At comparable cytotoxicity in both XPA and normal cells, BPD treatment induced more mutants and more DNA adducts than BPDE treatment did. At similar levels of DNA adducts in XPA cells, the levels of cytotoxicity induced by CYP1A1-metabolized BPD and exogenously supplied BPDE were similar, but CYP1A1-metabolized BPD induced a threefold higher hypoxanthine phosphoribosyltransferase mutation frequency. In contrast, at similar levels of adducts in CYP1A1-expressing normal cells, BPD induced less cytotoxicity and a lower mutation frequency. DNA adducts were identified and quantified by 32P-postlabeling analyses. The principal adduct formed by both CYP1A1-metabolized BPD and exogenously supplied BPDE was 10-β-(deoxyguanosin-N2-yl)-7β,8α,9α-trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene, indicating that the differential effects of BPD- and BPDE-induced adducts were not due to a difference in the types of adducts formed. The results of these studies suggest that CYP1A1-metabolized BPD may form adducts preferentially in transcriptionally active genes or that the intracellular concentration of BPDE may influence the balance between cytotoxicity and mutagenicity (or both). © 1995 Wiley-Liss Inc." @default.
• W2140450303 created "2016-06-24" @default.
• W2140450303 creator A5019337695 @default.
• W2140450303 creator A5031482106 @default.
• W2140450303 creator A5047076982 @default.
• W2140450303 creator A5048851156 @default.
• W2140450303 creator A5056650076 @default.
• W2140450303 date "1995-02-01" @default.
• W2140450303 modified "2023-10-16" @default.
• W2140450303 title "Differential mutagenicity and cytotoxicity of (±)-benzo[a]pyrene-trans-7,8-dihydrodiol and (±)-anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9, 10-epoxide in genetically engineered human fibroblasts" @default.
• W2140450303 cites W1493732561 @default.
• W2140450303 cites W1622527135 @default.
• W2140450303 cites W1963790546 @default.
• W2140450303 cites W1967221425 @default.
• W2140450303 cites W1985617772 @default.
• W2140450303 cites W1988711085 @default.
• W2140450303 cites W1989896073 @default.
• W2140450303 cites W2000009240 @default.
• W2140450303 cites W2016081901 @default.
• W2140450303 cites W2016449323 @default.
• W2140450303 cites W2023617923 @default.
• W2140450303 cites W2024896348 @default.
• W2140450303 cites W2028851148 @default.
• W2140450303 cites W2032051056 @default.
• W2140450303 cites W2033182016 @default.
• W2140450303 cites W2038399829 @default.
• W2140450303 cites W2040101006 @default.
• W2140450303 cites W2051040286 @default.
• W2140450303 cites W2071989101 @default.
• W2140450303 cites W2081412315 @default.
• W2140450303 cites W2086389658 @default.
• W2140450303 cites W2088524561 @default.
• W2140450303 cites W2101026512 @default.
• W2140450303 cites W2102869567 @default.
• W2140450303 cites W2107753038 @default.
• W2140450303 cites W2128442121 @default.
• W2140450303 cites W2136881844 @default.
• W2140450303 cites W2167525878 @default.
• W2140450303 cites W2154474090 @default.
• W2140450303 doi "https://doi.org/10.1002/mc.2940120206" @default.
• W2140450303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7662121" @default.
• W2140450303 hasPublicationYear "1995" @default.
• W2140450303 type Work @default.
• W2140450303 sameAs 2140450303 @default.
• W2140450303 citedByCount "13" @default.
• W2140450303 countsByYear W21404503032013 @default.
• W2140450303 countsByYear W21404503032016 @default.
• W2140450303 crossrefType "journal-article" @default.
• W2140450303 hasAuthorship W2140450303A5019337695 @default.
• W2140450303 hasAuthorship W2140450303A5031482106 @default.
• W2140450303 hasAuthorship W2140450303A5047076982 @default.
• W2140450303 hasAuthorship W2140450303A5048851156 @default.
• W2140450303 hasAuthorship W2140450303A5056650076 @default.
• W2140450303 hasConcept C104317684 @default.
• W2140450303 hasConcept C109316439 @default.
• W2140450303 hasConcept C114246631 @default.
• W2140450303 hasConcept C134935766 @default.
• W2140450303 hasConcept C143065580 @default.
• W2140450303 hasConcept C153911025 @default.
• W2140450303 hasConcept C185592680 @default.
• W2140450303 hasConcept C202751555 @default.
• W2140450303 hasConcept C2776639595 @default.
• W2140450303 hasConcept C2777538855 @default.
• W2140450303 hasConcept C2778378917 @default.
• W2140450303 hasConcept C2778951431 @default.
• W2140450303 hasConcept C2781247443 @default.
• W2140450303 hasConcept C552990157 @default.
• W2140450303 hasConcept C55493867 @default.
• W2140450303 hasConcept C78179603 @default.
• W2140450303 hasConcept C86803240 @default.
• W2140450303 hasConcept C87355193 @default.
• W2140450303 hasConceptScore W2140450303C104317684 @default.
• W2140450303 hasConceptScore W2140450303C109316439 @default.
• W2140450303 hasConceptScore W2140450303C114246631 @default.
• W2140450303 hasConceptScore W2140450303C134935766 @default.
• W2140450303 hasConceptScore W2140450303C143065580 @default.
• W2140450303 hasConceptScore W2140450303C153911025 @default.
• W2140450303 hasConceptScore W2140450303C185592680 @default.
• W2140450303 hasConceptScore W2140450303C202751555 @default.
• W2140450303 hasConceptScore W2140450303C2776639595 @default.
• W2140450303 hasConceptScore W2140450303C2777538855 @default.
• W2140450303 hasConceptScore W2140450303C2778378917 @default.
• W2140450303 hasConceptScore W2140450303C2778951431 @default.
• W2140450303 hasConceptScore W2140450303C2781247443 @default.
• W2140450303 hasConceptScore W2140450303C552990157 @default.
• W2140450303 hasConceptScore W2140450303C55493867 @default.
• W2140450303 hasConceptScore W2140450303C78179603 @default.
• W2140450303 hasConceptScore W2140450303C86803240 @default.
• W2140450303 hasConceptScore W2140450303C87355193 @default.
• W2140450303 hasIssue "2" @default.
• W2140450303 hasLocation W21404503031 @default.
• W2140450303 hasLocation W21404503032 @default.
• W2140450303 hasOpenAccess W2140450303 @default.
• W2140450303 hasPrimaryLocation W21404503031 @default.
• W2140450303 hasRelatedWork W1498673462 @default.
• W2140450303 hasRelatedWork W1997248328 @default.
• W2140450303 hasRelatedWork W2000722792 @default.
• W2140450303 hasRelatedWork W2013721205 @default.

• next